Clinical Trials on Patients With Moderate to Severe Perioral Lines in United Kingdom
Total 146 results
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
Merz North America, Inc.Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
Astellas Pharma Europe Ltd.CompletedModerate to Severe Vasomotor SymptomsUnited Kingdom
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical CorporationCompletedMild to Moderate Temporal Atrophy | Moderate to Severe Glabellar Rhytids | Moderate to Severe Periorbital RhytidsUnited States
-
AllerganCompletedModerate to Severe Nasolabial FoldsUnited States
-
Croma-Pharma GmbHActive, not recruitingModerate to Severe Midface Volume DeficitUnited States
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
George Washington UniversityJohns Hopkins UniversityCompletedPatients With Peripheral Intravenous Access LinesUnited States
-
San Diego Veterans Healthcare SystemCongressionally Directed Medical Research ProgramsCompletedPTSD With a History of Mild to Moderate TBIUnited States
-
PfizerCompleted
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial FoldsUnited States
-
QRxPharma Inc.CompletedAcute Moderate to Severe PainUnited States
-
Lindner Center of HOPEUniversity of Cincinnati; AbbottCompletedBipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild ManiaUnited States
-
BioPharmX, Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Actavis Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
University Hospitals, LeicesterCompletedAssess Effect of Omega-3 Fish Oil in Patients With Severe Acute PancreatitisUnited Kingdom
-
University of California, IrvineWithdrawnAnesthetized Healthy Patients (ASA 1 or 2) in the Supine Position, Excluding Head, Neck and Head Surgeries | Anesthetized Patient With Severe Systemic Disease (ASA 3 or 4)United States
-
Brahms AGRecruitingPatients Presenting With Suspicion of Infection to the EDUnited Kingdom, Spain, Italy, France
-
Wake Forest University Health SciencesCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
King's College LondonUnknownModerate to Severe Alzheimer's DiseaseUnited Kingdom
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Plaque PsoriasisUnited States, Canada, Germany, Poland
-
Bristol-Myers SquibbTerminatedPsoriasis, Moderate to SevereUnited States
-
University of California, San FranciscoCompletedModerate to Severe PsoriasisUnited States
-
Medivation, Inc.PfizerTerminatedModerate to Severe AlzheimerChile, United Kingdom
-
Tufts Medical CenterCentocor, Inc.CompletedModerate to Severe Palmar Plantar PsoriasisUnited States
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
Grünenthal GmbHDepomedTerminatedModerate to Severe Acute Postoperative PainUnited States, United Kingdom, Poland
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque PsoriasisUnited States
-
Biosplice Therapeutics, Inc.CompletedModerate to Severe OsteoarthritisUnited States
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
Sun Pharmaceutical Industries LimitedRecruitingModerate to Severe Plaque PsoriasisUnited States, El Salvador
-
Dong-A ST Co., Ltd.Meiji Seika Pharma Co., Ltd.CompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Biocon Biologics UK LtdActive, not recruitingModerate to Severe Chronic Plaque PsoriasisUnited States
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Nektar TherapeuticsTerminatedModerate to Severe Chronic PainUnited States
-
PollogenLumenis Be Ltd.RecruitingModerate to Severe Acne VulgarisUnited States
-
AcelRx Pharmaceuticals, Inc.U.S. Army Medical Research and Development CommandCompletedModerate-to-severe Acute PainUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
AbbVie (prior sponsor, Abbott)Paragon BiomedicalCompletedModerate to Severe Plaque PsoriasisUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more